Medivir

Gilead-Medivir Hepatitis C Drug Clears Virus in Patients

Gilead-Medivir Hepatitis C Drug Clears Virus in Patients

Bloomberg

Invest in the Great Progress of Hepatitis C

Invest in the Great Progress of Hepatitis C

Motley Fool

Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry

Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry

Seeking Alpha

Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover

Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover

Bloomberg

Medivir Announces TMC435 in an Expanded Clinical Collaboration

Medivir Announces TMC435 in an Expanded Clinical Collaboration

Yahoo

10 Hep C Stocks on Wall Street's Watch List

10 Hep C Stocks on Wall Street's Watch List

TheStreet.com

Four Biotech Picks to Fight Hepatitis C

Four Biotech Picks to Fight Hepatitis C

Barron's

J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says

J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says

Bloomberg

Medivir: terms of herpes-drug venture are reset

Medivir: terms of herpes-drug venture are reset

Marketwatch

News

Medivir Shares Gain After Hepatitis C Drug Test Results Released

Bloomberg